Agarikon (Fomitopsis officinalis): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does Agarikon mushroom work as an antiviral?

Agarikon contains chlorinated coumarins, agaric acid, and beta-glucans that demonstrate antiviral activity in laboratory studies. These compounds appear to inhibit viral replication and modulate immune response. The chlorinated coumarins are particularly notable for antimicrobial effects against respiratory pathogens. Research has shown activity against influenza viruses in vitro. However, human clinical trials are lacking, and evidence remains at Level C (preliminary). Traditional use spans centuries, but the exact mechanisms require further investigation.

Does Agarikon interact with any medications?

Limited research exists on Agarikon drug interactions. Theoretical concerns include potential interactions with immunosuppressive medications due to its immune-modulating effects. The presence of agaric acid suggests possible interactions with anticoagulants, though this remains unconfirmed. Patients taking tuberculosis medications or antiviral drugs should consult a healthcare provider before use, as Agarikon may affect treatment outcomes. Always disclose all supplements to your prescribing physician.

What is the recommended dosage of Agarikon?

The typical adult dosage is 500-1000mg of Agarikon extract daily, usually divided into one or two doses. This recommendation is based on traditional use and available product formulations rather than clinical trial data. Those new to Agarikon should start at 500mg to assess tolerance. Standardized extracts provide more consistent dosing. Consult a qualified healthcare practitioner for condition-specific recommendations, as duration and dosage may vary based on individual needs.

Is Agarikon safe during pregnancy and breastfeeding?

Agarikon is considered unsafe during pregnancy and breastfeeding. The bioactive compounds, including agaric acid, may pose risks to fetal development, and insufficient safety data exists for pregnant or nursing populations. Women who are pregnant, planning pregnancy, or breastfeeding should avoid Agarikon entirely. Historical use was restricted to non-pregnant adults for respiratory conditions. Always consult a healthcare provider before using any medicinal mushroom supplement during pregnancy.

What is Agarikon mushroom used for?

Agarikon has been traditionally used for tuberculosis, respiratory infections, chronic cough, and wound healing. Hippocrates referred to it as an 'elixir for long life.' Modern interest focuses on its antiviral and antimicrobial properties, with preliminary research suggesting activity against influenza and other respiratory pathogens. Evidence supporting these uses is Level C (preliminary), meaning more rigorous human studies are needed. Indigenous peoples of the Pacific Northwest also used it medicinally for lung ailments.

What are the side effects of Agarikon?

Reported side effects of Agarikon are primarily gastrointestinal and include nausea, stomach upset, and digestive discomfort. These effects are more common when taken on an empty stomach or at higher doses. Individuals with gastrointestinal sensitivity may experience more pronounced symptoms. Taking Agarikon with food and starting with lower doses may minimize adverse effects. Discontinue use if severe symptoms occur. Those with mushroom allergies should exercise caution. Long-term safety data remains limited.

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Agarikon (Fomitopsis officinalis) is a medicinal polypore mushroom with documented antimicrobial, antioxidant, and antitumor properties [PMID:30834150, 32271491, 34102992].

Contexte

Fomitopsis officinalis, also known as Laricifomes officinalis or Quinine conk, is an arboreal medicinal mushroom that grows on old standing trees, fallen logs, or stumps [PMID:30834150, 32271491, 37107128]. It has a long history of use in European and Asian folk medicine and was mass-collected for 18th and 19th-century pharmacy [PMID:32271491, 34591396].

Usages traditionnels

Traditionally used to treat pulmonary diseases, cough, and asthma in Mongolian and Chinese medicine [PMID:30834150, 34102992, 41050420]. It has also been used for rheumatism in Mongolia [PMID:29417466] and was a component of 'Swedish Bitters' in early modern European medicine [PMID:27603304].

Composés actifs

Bioactive components include polysaccharides (such as mannofucogalactan and branched β-glucan), triterpenoids (lanostane-type), chlorinated coumarins, phenolic compounds, organic acids, flavonoids, saponins, and cytokinins (zeatin-type) [PMID:30143116, 30834150, 32271491, 32353551, 33822496, 39262658].

Mécanisme d'action

Antitumor effects are associated with the activation of immunity, inhibition of angiogenesis [PMID:38569989, 38788870], and the NF-kB signaling pathway [PMID:34102992].

Preuves cliniques

Preuve DChronic Obstructive Pulmonary Disease (COPD)

Agarikon pill (AGKP) improved lung function and pathological changes in rat models [PMID:39262658]

Preuve DHepatocellular Carcinoma

Chloroformic extracts promoted cancer cell apoptosis in HepG2 and LO2 cell lines in vitro [PMID:34102992]

Preuve DColorectal Cancer

Medicinal mushroom preparations (AGARIKON.1 and AGARIKON PLUS) showed antiproliferative and pro-apoptotic effects on HCT-116 and SW620 tumor cell lines in vitro [PMID:33126765]

Preuve DMycobacterium tuberculosis

Chlorinated coumarins isolated from the mushroom demonstrated antimicrobial activity against the M. tuberculosis complex [PMID:24087924]

Preuve DTrypanosoma congolense

Lanostane triterpenoids exhibited moderate inhibitory activity (IC50 7.0-27.1 μM) [PMID:29417466]

Sécurité et effets indésirables

Some studies describe medicinal mushroom preparations as non-toxic multi-target inhibitors [PMID:33126765].

Synthèse des preuves

The current evidence is primarily based on in vitro studies, animal models (rats, mice, zebrafish), and historical reviews. There are no human clinical trials provided in the abstracts.

Sources PubMed

1.PMID: 40370689 (2024) — Neuroprotective Mushrooms. · NeuroImmune pharmacology and therapeutics
2.PMID: 30834150 (2019) — Antimicrobial properties of Fomitopsis officinalis in the light of its bioactive metabolites: a review. · Mycology
3.PMID: 32271491 (2020) — Fomitopsis officinalis: a Species of Arboreal Mushroom with Promising Biological and Medicinal Properties. · Chemistry & biodiversity
4.PMID: 30143116 (2018) — Structure characterization of the mannofucogalactan isolated from fruit bodies of Quinine conk Fomitopsis officinalis. · Carbohydrate polymers
5.PMID: 34102992 (2022) — Anti-oxidant and Anticancerous Effect of Fomitopsis officinalis (Vill. ex Fr. Bond. et Sing) Mushroom on Hepatocellular Carcinoma Cells In Vitro through NF-kB Pathway. · Anti-cancer agents in medicinal chemistry

Agarikon

Sources et citations

Calculer une dose sûre de Agarikon

Plantago lanceolata

Waltheria Indica

Lomatium Root

Questions fréquentes

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales

Agarikon

Sources et citations

Calculer une dose sûre de Agarikon

Plantes associées

Plantago lanceolata

Waltheria Indica

Lomatium Root

Questions fréquentes

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales